Early research (Phase 1)Study completedNCT00720148What this trial is testingA Phase I Trial of Bortezomib and SunitinibWho this might be right forSolid Tumors Emory University 30
Early research (Phase 1)Study completedNCT02451553What this trial is testingAfatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary CancerWho this might be right forAdvanced Malignant Solid NeoplasmBile Duct CarcinomaRecurrent Malignant Solid Neoplasm+4 more University of Washington 41
Early research (Phase 1)Ended earlyNCT02703571What this trial is testingStudy of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid TumorsWho this might be right forSolid Tumors for Phase IbPancreatic Cancer for Phase IIColorectal Cancer for Phase II Novartis Pharmaceuticals 95
Testing effectiveness (Phase 2)Looking for participantsNCT07512583What this trial is testingClinical Studies of TQB2930 Injection for the Treatment of Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 178
Testing effectiveness (Phase 2)Looking for participantsNCT06703177What this trial is testingSHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid TumorsWho this might be right forAdvanced Solid Tumors Suzhou Suncadia Biopharmaceuticals Co., Ltd. 876
Testing effectiveness (Phase 2)UnknownNCT06092268What this trial is testingA Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Suzhou Suncadia Biopharmaceuticals Co., Ltd. 270
Early research (Phase 1)Looking for participantsNCT05857332What this trial is testingSG1906 for CLDN18.2-Positive Solid TumorsWho this might be right forLocally Advanced Unresectable or Metastatic Solid Tumors Hangzhou Sumgen Biotech Co., Ltd. 60
Early research (Phase 1)Study completedNCT01673737What this trial is testingA Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced CancerWho this might be right forNeoplasm Malignant Sanofi 75
Testing effectiveness (Phase 2)Looking for participantsNCT06031584What this trial is testingBL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal TumorsWho this might be right forHer2-positive/Low-expression Urinary and Digestive Tract Tumors Sichuan Baili Pharmaceutical Co., Ltd. 42
Testing effectiveness (Phase 2)Looking for participantsNCT07441174What this trial is testingIN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid TumorsWho this might be right forSolid Tumor CancerPDAC InxMed (Shanghai) Co., Ltd. 92
Early research (Phase 1)Study completedNCT03520504What this trial is testingStudy of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal MetastasesWho this might be right forLeptomeningeal Metastases Memorial Sloan Kettering Cancer Center 24
Early research (Phase 1)Study completedNCT01570296What this trial is testingA Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFRWho this might be right forNon-Small Cell Lung CancerSolid Tumors National Cancer Centre, Singapore 38
Early research (Phase 1)Study completedNCT01468922What this trial is testingPazopanib and ARQ 197 for Advanced Solid TumorsWho this might be right forSolid Tumor National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Looking for participantsNCT07371663What this trial is testingAn Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsWho this might be right forSolid CancersNSCLC (Advanced Non-small Cell Lung Cancer)Gastric (Stomach) Cancer+2 more Beijing Tide Pharmaceutical Co., Ltd 266
Early research (Phase 1)Study completedNCT00375245What this trial is testingRapamycin With Grapefruit Juice for Advanced MalignanciesWho this might be right forTumorsNeoplasm Metastasis University of Chicago 41
Testing effectiveness (Phase 2)Looking for participantsNCT07382531What this trial is testingOH2 Injection in Combination With BS006 Injection for Advanced Solid TumorsWho this might be right forSolid Tumor Binhui Biopharmaceutical Co., Ltd. 30
Early research (Phase 1)UnknownNCT05989724What this trial is testingA First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid TumorsWho this might be right forSolid TumorBreast CancerPancreatic Cancer+2 more Qurgen Inc. 150
Testing effectiveness (Phase 2)Study completedNCT00070252What this trial is testingNeoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast CancerWho this might be right forAdult Solid NeoplasmInflammatory Breast CarcinomaMale Breast Carcinoma+2 more National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Looking for participantsNCT06825494What this trial is testingClinical Studies for the Treatment of Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 194
Early research (Phase 1)Looking for participantsNCT03816345What this trial is testingTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOWho this might be right forAutoimmune DiseaseCrohn DiseaseDermatomyositis+11 more National Cancer Institute (NCI) 300